Planning pregnancy, a possible pregnancy and breastfeeding are different situations. They need coordinated clinical planning, especially when diabetes is also being treated. General statements about “weight-loss injections” can hide important differences. This guide uses EU information checked on 16 October 2026.
Raise pregnancy plans early
Tell your prescribing clinician if pregnancy is planned or may be relevant in the foreseeable future. The issue is more than the final administration date: care before and during pregnancy needs coordination. More than one professional may be involved.
Bring the exact product name, ingredient and formulation. Official information specifies different lead-in intervals for different ingredients. Have the requirement for your prescription explained and recorded. A treatment break assembled from internet posts is not a substitute for that planning.
What EU information says about pregnancy
Wegovy containing semaglutide must not be used during pregnancy. Current Mounjaro information does not recommend tirzepatide during pregnancy. A weight-management plan used beforehand therefore cannot simply be carried into pregnancy unchanged.
If you are pregnant or suspect pregnancy, contact the prescribing clinician promptly to clarify what to do about the medicine and arrange care. Do not wait for an ordinary follow-up appointment. Record the product and previous use without attempting to calculate your personal risk from general information.
Breastfeeding is a separate question
Wegovy must not be used during breastfeeding either. For tirzepatide, current European product information instead allows an individual clinical assessment: use during breastfeeding may be considered. This is neither a general recommendation nor a guarantee of safety.
The statements concern particular products and the current document version. The child’s age and circumstances, your health and nutrition during breastfeeding belong in the discussion. Do not rely on an older blanket prohibition or a reassuring experience posted in a forum.
Clarify contraception for the actual product
Ask what contraception is appropriate during your treatment and whether other medicines matter. Tirzepatide advice can differ between regulatory regions. A US or UK recommendation must not automatically be presented as an identical EU requirement.
Vomiting, diarrhoea or a missed contraceptive dose also raise questions under that contraceptive’s own instructions. Obtain timely professional advice rather than deducing an answer from the general GLP-1 mechanism. Changes in your cycle are not a replacement for reliable contraception or clinical assessment.
Keep the rest of your treatment in view
If you have diabetes, planning glucose management is particularly important. Changing a weight medicine does not automatically establish how other necessary treatment will continue. Do not independently reduce or replace those medicines.
Ask for a clear overall plan: who is responsible, which checks are needed and how to reach the team after a positive test or with new questions. Meals, nausea, drinking and distress can be discussed too. Good advice should provide orientation without blame or premature assurances about individual risk.
Common questions
Is breastfeeding advice the same for all GLP-1 medicines?
No. Ingredients and current product information differ. Wegovy and Mounjaro cannot be accurately covered by one blanket statement here. Discuss your actual product and circumstances.
Can I choose the timing of a treatment break myself?
Plan it with your prescriber. The ingredient, treatment circumstances and other necessary care matter. The product-specific requirement should be explained without overlooking the rest of your treatment.
Sources & further reading
- EMA: Wegovy – EPAR und Produktinformation
- EMA: Mounjaro – EPAR und Produktinformation
- WHO: GLP-1 therapies for obesity, 1 December 2025
Sources checked:
Questions and experiences
Share a question or a useful experience about this topic. Every contribution is checked before publication. Comments may be written in different languages.
Loading reader contributions…
Opening the form sets a necessary session cookie. No email address is required. Publication is subject to moderation and is not guaranteed. For deletion requests: Contact